A Text Messaging-Based Smoking Cessation Program for Adult Smokers: Randomized Controlled Trial

por Ybarra, Michele, Bağcı Bosi, A Tülay, Korchmaros, Josephine, Emri, Salih
Publicado 2012

Correction: A Text Messaging-Based Smoking Cessation Program for Adult Smokers: Randomized Controlled Trial

por Ybarra, Michele, Bağci Bosi, A Tülay, Korchmaros, Josephine, Emri, Salih
Publicado 2015

P1555: IRON CHELATION THERAPY IN CONGENITAL HEMOLYTIC ANEMIAS: AN ITALIAN SINGLE CENTER STUDY

por Bosi, A., Fattizzo, B., Giannotta, J. A., Papetti, I., Barcellini, W.
Publicado 2022

Design Considerations in Developing a Text Messaging Program Aimed at Smoking Cessation

por Ybarra, Michele L, Holtrop, Jodi Summers, Bağci Bosi, A Tülay, Emri, Salih
Publicado 2012

Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas.

por Bellesi, G., Alterini, R., Messori, A., Bosi, A., Bernardi, F., di Lollo, S., Ferrini, P. R.
Publicado 1989

Interest in technology-based and traditional smoking cessation programs among adult smokers in Ankara, Turkey

por Ybarra, Michele L, Bağci Bosi, A Tülay, Bilir, Nazmi, Holtrop, Jodi S, Korchmaros, Josephine, Emri, Salih
Publicado 2011

Proposed definition of ‘poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo

por Olivieri, A, Marchetti, M, Lemoli, R, Tarella, C, Iacone, A, Lanza, F, Rambaldi, A, Bosi, A
Publicado 2012

Role of critical care outreach to provide the intention to treat of hematological disorders: a pilot study

por Guerri, I, Greco, C, Perretta, L, Cianfaldoni, G, Longo, G, Batacchi, S, Spina, R, Bosi, A, Zagli, G, Peris, A
Publicado 2010

PB1840: MONOCENTRIC EXPERIENCE OF VENETOCLAX-BASED REGIMENS FOR ACUTE MYELOID LEUKEMIA

por Sciumè, M., Bosi, A., Ceparano, G., De Magistris, C., Serpenti, F., De Roberto, P., Galassi, G., Onida, F., Fracchiolla, N. S.
Publicado 2022

Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value

por Vannucchi, A M, Rotunno, G, Bartalucci, N, Raugei, G, Carrai, V, Balliu, M, Mannarelli, C, Pacilli, A, Calabresi, L, Fjerza, R, Pieri, L, Bosi, A, Manfredini, R, Guglielmelli, P
Publicado 2014

Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine

por Valencia, A, Masala, E, Rossi, A, Martino, A, Sanna, A, Buchi, F, Canzian, F, Cilloni, D, Gaidano, V, Voso, M T, Kosmider, O, Fontenay, M, Gozzini, A, Bosi, A, Santini, V
Publicado 2014

Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients

por Rambaldi, A, Bacigalupo, A, Fanin, R, Ciceri, F, Bonifazi, F, Falda, M, Lambertenghi-Deliliers, G, Benedetti, F, Bruno, B, Corradini, P, Alessandrino, P E, Iacopino, P, Arcese, W, Scimè, R, Raimondi, R, Sica, S, Castagna, L, Lamparelli, T, Oneto, R, Lombardini, L, Pollichieni, S, Algarotti, A, Carobbio, A, Sacchi, N, Bosi, A
Publicado 2012

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospectiv...

por Todisco, E, Ciceri, F, Oldani, E, Boschini, C, Micò, C, VanLint, M T, Donnini, I, Patriarca, F, Alessandrino, P E, Bonifazi, F, Arcese, W, Barberi, W, Marenco, P, Terruzzi, E, Cortelazzo, S, Santarone, S, Proia, A, Corradini, P, Tagliaferri, E, Falcioni, S, Irrera, G, Dallanegra, L, Castagna, L, Santoro, A, Camboni, A, Sacchi, N, Bosi, A, Bacigalupo, A, Rambaldi, A
Publicado 2013